Clinical Trials
14 trialsNCT01013649 2026-02-23
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
National Cancer Institute (NCI)
Phase 3 Completed
NCT03199885 2025-12-30
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT01805076 2025-09-05
MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT05547386 2025-07-18
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer
Mayo Clinic
Phase 3 Completed
NCT03941860 2025-05-23
Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial
National Cancer Institute (NCI)
Phase 3 Completed
NCT01004978 2024-01-03
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 3 Completed
NCT00033293 2023-04-18
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
Children's Oncology Group
Phase 3 Completed
NCT02940262 2021-07-02
Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy
Jonsson Comprehensive Cancer Center
Phase 3 Completed
NCT00652769 2017-11-01
BOOST
University College London Hospitals
Phase 3 Completed
NCT01309334 2014-08-25
IMAJEM
Nantes University Hospital
Phase 3 Completed
NCT00265356 2013-10-21
PETCAM
Ontario Clinical Oncology Group (OCOG)
Phase 3 Completed
NCT00136890 2013-01-15
ELPET
Ontario Clinical Oncology Group (OCOG)
Phase 3 Completed
NCT00147472 2012-06-22
Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial)
Ontario Clinical Oncology Group (OCOG)
Phase 3 Completed
NCT00201942 2007-10-18
PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)
Ontario Clinical Oncology Group (OCOG)
Phase 3 Completed